• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABIOMED, INC. IMPELLA CP; TEMPORARY CARDIAC SUPPORT BLOOD PUMP, PRODUCT CODE: OZD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABIOMED, INC. IMPELLA CP; TEMPORARY CARDIAC SUPPORT BLOOD PUMP, PRODUCT CODE: OZD Back to Search Results
Model Number IMPELLA CP
Device Problems Break (1069); Difficult or Delayed Positioning (1157); Physical Resistance (2578); Patient-Device Incompatibility (2682)
Patient Problem Blood Loss (2597)
Event Date 12/20/2016
Event Type  Injury  
Manufacturer Narrative
The investigation of this event included a review of the clinical case and console data, however the pump has not yet been returned for analysis.The console data confirmed the clinical account.The pump primed successfully and provided support for two minutes before the device was stopped by the user.The pump was never turned back on due to the reported issue with the introducer and separated inflow cage.According to the clinical description insertion of the pump was difficult due to the patient's heavily calcified and tortuous vasculature.As listed in the ifu under contraindications: "severe peripheral arterial disease that precludes the placement of an impella cp catheter." as the pci procedure began the sentrant introducer slid out of the artery; requiring repositioning.In order to re-insert the introducer the impella was pulled back through the introducer, however the inflow cage became separated from the catheter at this time.The root cause of the inflow cage separation from the catheter is most likely due to the patient's peripheral vasculature disease, and heavily calcified and tortuous vasculature.The impella cp has not yet been returned for evaluation as it is being held in the facility's risk management department.The manufacturer will continue to investigate all reasonable and obtainable sources of information and will supply results and conclusions in a supplemental medwatch report if the device and/or additional information is received.(b)(4).Product not yet received.
 
Event Description
An (b)(6) female with a history of peripheral vascular disease, severe microvascular disease, coronary ostial stenosis and chronic total occlusion of the right coronary artery was scheduled for a high-risk pci procedure on (b)(6) 2016.The plan was to implant impella cp for support during the rotational atherectomy portion of the hrpci.Rescue angioplasty with stenting of the left main and left anterior descending was performed.The patient began to decompensate at 5 am and the decision was made to implant impella cp through the right axillary insertion site.A 14 x 28 fr sentrant sheath was inserted with difficulty due to heavy calcified and tortuous vasculature.The vascular surgeon inserted the sheath into the right axillary using ultrasound, and the impella cp was advanced.The pump was started without issue, however when the pci procedure began the sentrant sheath slipped out of the artery.To prepare for repositioning of the device, the pump was pulled back across the valve into the axillary artery to the access site; and the decision was made to reposition the device wirelessly.When the clinical team attempted to pull the pump back into the sheath the pump became lodged in calcium.As the sheath and pump were attempted to be maneuvered around the calcium, the inflow cage separated from the catheter.The separated inflow cage was noted to be securely in the subclavian artery and not in the carotid artery, therefore the decision was made to implant a second impella cp through the left femoral artery in order to complete the pci procedure.The second impella cp was implanted and the pci was successfully completed, however the patient was pulseless throughout the procedure.The clinical team attempted to remove the inflow cage through the right subclavian sheath using a guide wire snare and 5 mm balloon, however they were unsuccessful.A 14 fr introducer was inserted into the right femoral artery where the inflow cage and pigtail were successfully removed.The right femoral insertion site was unable to be successfully closed using a perclose closure device, therefore a covered stent was placed for hemostasis.Throughout the course of the procedure the patient received 4 units of blood products, however it was unclear if the blood replacement was needed due to the pump separation or due to access of the patient's anatomy.The patient was transported to ccu in stable condition and on impella cp support.The patient subsequently expired as a result of multi-system organ failure following 25 hours of successful impella cp support.
 
Manufacturer Narrative
The investigation of this event included a review of the clinical case and console data that was conducted previously, and the pump has since been returned for evaluation.The pump was returned with the inflow cage separated from the cannula, and the pigtail was deformed and kinked.The cannula is made of a nitinol coil surrounded on both sides by polyurethane.The polyurethane coating had ripped and the nitinol coil had been pulled out of the remaining coating.The bond between the cannula and inflow cage did not fail.There was evidence of a kink right where the polyurethane coating had ripped.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPELLA CP
Type of Device
TEMPORARY CARDIAC SUPPORT BLOOD PUMP, PRODUCT CODE: OZD
Manufacturer (Section D)
ABIOMED, INC.
22 cherry hill drive
danvers MA 01923
Manufacturer (Section G)
ABIOMED, INC.
22 cherry hill drive
danvers MH 01923
Manufacturer Contact
william bolt
22 cherry hill drive
danvers, MA 01923
MDR Report Key6260115
MDR Text Key65059913
Report Number1220648-2017-00005
Device Sequence Number1
Product Code OZD
UDI-Device Identifier00813502011258
UDI-Public00813502011258
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P1400003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/20/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/18/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date08/31/2018
Device Model NumberIMPELLA CP
Device Catalogue Number0048-0003
Device Lot Number1258949
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/20/2017
Is the Reporter a Health Professional? Yes
Event Location Hospital
Date Manufacturer Received02/14/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/30/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
THE 14 X 28 FR SENTRANT SHEATH
Patient Outcome(s) Required Intervention;
Patient Age82 YR
-
-